VOYA Investment Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Sell |
246,114
-146,810
| -37% | -$6.93M | 0.01% | 690 |
|
|
2025
Q1 | $15.4M | Sell |
392,924
-55,936
| -12% | -$2.19M | 0.02% | 607 |
|
|
2024
Q4 | $24.3M | Buy |
448,860
+39,657
| +10% | +$2.15M | 0.03% | 485 |
|
|
2024
Q3 | $20.6M | Buy |
409,203
+350,958
| +603% | +$17.7M | 0.02% | 540 |
|
|
2024
Q2 | $2.56M | Sell |
58,245
-5,490
| -9% | -$241K | ﹤0.01% | 1241 |
|
|
2024
Q1 | $3.2M | Sell |
63,735
-9,325
| -13% | -$468K | ﹤0.01% | 1163 |
|
|
2023
Q4 | $4.41M | Buy |
73,060
+37,970
| +108% | +$2.29M | ﹤0.01% | 1048 |
|
|
2023
Q3 | $2M | Hold |
35,090
| – | – | ﹤0.01% | 1333 |
|
|
2023
Q2 | $1.79M | Buy |
+35,090
| New | +$1.79M | ﹤0.01% | 1393 |
|